We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

By LabMedica International staff writers
Posted on 13 Nov 2024
Print article
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly monitor the concentration of these drugs in their bodies. However, the current diagnostic technologies used in hospitals for this purpose face challenges in terms of both accuracy and time efficiency. The most widely used method, immunoassay, is prone to cross-reactions with similar drugs, which lowers diagnostic accuracy. While mass spectrometry, which ionizes samples using electrospray, offers greater accuracy, it is time-consuming and expensive, creating additional burdens for patients. To address these limitations, researchers have developed a novel diagnostic and treatment system based on nanomaterials for therapeutic drug monitoring (TDM) in epilepsy patients. This approach promises to significantly reduce the time and cost of current diagnostics while maintaining accuracy, ultimately easing the burden on patients managing their condition.

This innovative nanomaterial-based diagnostic method was developed by scientists at the Korea Research Institute of Standards and Science (KRISS, Daejeon, South Korea), in collaboration with domestic university hospitals. By incorporating a mixture of molybdenum ditelluride (MoTe2) and tungsten ditelluride (WTe2) nanosheets into the sample and ionizing it with a laser, the researchers were able to enhance both the speed and sensitivity of drug detection. When applied to samples from 120 epilepsy patients, the technology demonstrated over 99.9% reliability, while reducing the analysis time to just one-sixteenth of the original. Furthermore, the number of samples that could be analyzed in a single session increased more than tenfold, potentially cutting diagnostic costs by half.

Related Links:
KRISS

New
Gold Member
Strep Pneumoniae Rapid Test
Strep Pneumoniae (6503 – 6573)
Gold Member
Troponin T QC
Troponin T Quality Control
New
Washer Disinfector
Tiva 8
New
Chikungunya Rapid Test
Chikungunya IgG/IgM Rapid Test Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The test is intended for the early detection of lung cancer when curative surgical resection is possible (Photo courtesy of Cizzle Biotechnology)

Revolutionary Early Lung Cancer Blood Test to Enable Faster Treatment

Lung cancer is one of the most prevalent cancers globally, with over 2 million new cases reported in 2018. Unfortunately, the majority of lung cancer cases have already metastasized by the time they are diagnosed.... Read more

Immunology

view channel
Image: Concept for the device. Memory B cells able to bind influenza virus remain stuck to channels despite shear forces (Photo courtesy of Steven George/UC Davis)

Microfluidic Chip-Based Device to Measure Viral Immunity

Each winter, a new variant of influenza emerges, posing a challenge for immunity. People who have previously been infected or vaccinated against the flu may have some level of protection, but how well... Read more

Microbiology

view channel
Image: The QuickMIC system (Photo courtesy of Gradientech)

Ultra-Rapid AST System Provides Critical Results for Sepsis Patients

Sepsis is a critical condition and one of the leading causes of death in hospitals. Millions of adults are diagnosed with sepsis each year, and it is also a primary reason for hospital readmissions.... Read more

Pathology

view channel
Image: Research has revealed new insights about how \'bad\' cholesterol works in the body (Photo courtesy of Shutterstock)

Advanced Imaging Technique Helps See Low-Density Lipoprotein-Cholesterol in New Light

Low-density lipoprotein cholesterol (LDL-C), often referred to as "bad cholesterol," is a major contributor to cardiovascular disease, the leading cause of death worldwide, claiming one life every 33 seconds.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.